87 / 89
87
129.
Kahan A, Allanore Y. Primary myocardial
involvement
in
systemic
sclerosis.
Rheumatology (Oxford) 2006;45(Suppl.4):iv14-
7.
130.
Ishida R, Murata Y, Sawada Y, Nishioka K,
Shibuya H. Thallium-201 myocardial SPET in
patients with collagen disease. Nucl Med
Commun 2000;21:729-34.
131.
Akram MR, Handler CE, Williams M, Carulli
MT, Andron M, Black CM, et al.
Angiographically proven coronary artery
disease
in
scleroderma.
Rheumatology
(Oxford) 2006;45:1395-8.
132.
Kahan A, Devaux JY, Amor B, Menkes CJ,
Weber S, Foult JM, et al. Pharmacodynamic
effect of dipyridamole on thallium-201
myocardial perfusion in progressive systemic
sclerosis with diffuse scleroderma. Ann
Rheum Dis 1986;45:718-25.
133.
Kahan A, Devaux JY, Amor B, Menkès CJ,
Weber S, Nitenberg A, et al. Nifedipine and
thallium-201
myocardial
perfusion
in
progressive systemic sclerosis. N Engl J Med
1986;314:1397-402.
134.
Kahan A, Devaux JY, Amor B, Menkes CJ,
Weber S, Venot A, et al. Nicardipine improves
myocardial perfusion in systemic sclerosis. J
Rheumatol 1988;15:1395-400.
135.
Kahan A, Devaux JY, Amor B, Menkès CJ,
Weber S, Venot A, et al. The effect of captopril
on thallium 201 myocardial perfusion in